Skip to main content
Edwards Lifesciences Logo
Edwards Lifesciences Logo

SAPIEN 3 transcatheter heart valve

Transcatheter sapien 3
Transcatheter sapien 3
Transcatheter sapien 3
background
background
background

Transformational valve design

Sealing skirt technology1

Edwards Commander Delivery System
Edwards Commander Delivery System
Edwards Commander Delivery System

Edwards Commander Delivery System: For predictable, proven results2

Delivering your strategy for lifetime management
through the eSheath+ Introducer Set

Delivering your strategy for lifetime
Delivering your strategy for lifetime
Delivering your strategy for lifetime
Controlled, low-profile vascular access for today's transcatheter aortic valve patients. Thoughtfully designed to:
  • Consistently reduce current and future patient complications
    (i.e vascular bleeding)3,4
  • Improve and simplify the implanter's experience†
  • Accelerate the preparation phase for the Heart Team†

Edwards commander delivery system

Features of the Edwards commander delivery system

Edwards Commander Delivery System
Edwards Commander Delivery System
Edwards Commander Delivery System
  • Allows for valve positioning and deployment
  • Dual articulation for coaxiality
  • Designed for precise positioning and deployment
  • Compatible with 14F /16F eSheath and Gore DrySeal Sheath
Edwards Commander Delivery System
Edwards Commander Delivery System
Edwards Commander Delivery System

Edwards eSheath introducer set

Features of the Edwards eSheath introducer set

eSheath Introducer Set Image
eSheath Introducer Set Image
eSheath Introducer Set Image
  • Hydrophilic coating designed for ease of insertion
  • 14F & 16F low-profile access
  • Dynamic Expansion Mechanism (DEM) for low-profile access
eSheath Introducer Set Image
eSheath Introducer Set Image
eSheath Introducer Set Image

Learn more about SAPIEN 3 TAVI* clinical evidence

*TAVI = Transcatheter Aortic Valve Implantation

Visit website for heart team

References

1. Nazif,et al. Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve. 2021
2. Webb J, Gerosa G, Lefèvre T, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64(21):2235-2243.
3. Thourani VH, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016 May 28;387(10034):2218-25)
4. Mack MJ, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019 May 2;380(18):1695-1705)
†Data on file at Edwards Lifesciences